Compare Johnson & Johnson (JNJ) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Vital Farms Inc — how do they compare? Johnson & Johnson trades at $261.49 (market cap $618.09B), while Vital Farms Inc trades at $9.47 (market cap $405.27M). The key difference: Johnson & Johnson is far larger — about 1525.1× Vital Farms Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Vital Farms Inc for 14 Days on average.
| JNJ | VITL | |
|---|---|---|
Market Cap | $618.09B | $405.27M |
Volume | 6,050,983 | 1,810,837 |
Sector | Health | Consumer Staples |
52-Week High | $278.43 | $43.68 |
52-Week Low | $186.00 | $8.28 |
Typical Hold Time | 129 Days | 14 Days |
Enterprise Value | $646.37B | $492.28M |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Vital Farms (VITL) trades at $9.33, showing modest daily gains but facing significant fundamental challenges. The company reported declining revenue and profitability in 2026, with net income margin collapsing to 0.02% from 8.72% in 2025. Technical indicators show bearish momentum, while analyst sentiment remains cautiously optimistic with a $13.11 consensus target. Recent news highlights strategic review possibilities and institutional accumulation despite operational headwinds.
The outlook remains challenging with pricing pressure and supply issues affecting margins, though strategic options exploration provides potential upside. Investment opportunity exists if operational improvements materialize, but risks include sustained margin compression and execution challenges in a competitive egg market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
